Clinical Trials Browser

INDUSTRY × Carcinoma, Non-Small-Cell Lung × 90 days × Clear all

Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Pancreatic Neoplasms

Clinical Trials

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

REVIVE

Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)

A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer

Dose Escalation Study of a PD1-LAG3 Bispecific Antibody in Patients With Advanced and/or Metastatic Solid Tumors

Study of DF1001 in Patients With Advanced Solid Tumors

Sasanlimab (PF-06801591, PD-1 Inhibitor) in Participants With Advanced Malignancies

Comparing the Efficacy and Safety of a New Additional Treatment With Tislelizumab in Non-Small Cell Lung Cancer (NSCLC)

A Study of DF6002 Alone and in Combination With Nivolumab

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

KontRASt-01

SYNERGY-101

CEMI-LUNG

A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer

A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

Study of DF6215 in Patients With Advanced Solid Tumors

PROSPER

ALAFOSS-01

LADOGA

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

Beamion LUNG-3: A Study to Test Whether Zongertinib Helps People With Surgically Removed, Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment

PEARLS

Chrysalis-2

Study of DS-1062a in Advanced or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05)

NIS durvalumab

VELOCITY-Lung

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in Participants With MTAP-deleted Solid Tumors

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

innovaTV 207

GEN1042 Safety Trial and Anti-tumor Activity in Participants With Malignant Solid Tumors

MK-3475-01A

MK-3475-U01

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Managed Access Programs for INC280, Capmatinib

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

ORI-EGI-03

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

KANDLELIT-004

TROPION-Lung10

CONVERGE

KANDLELIT-007

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

SYS6090 Combination Therapy in Advanced Lung Cancer